Skip to Content
You are currently on the new version of our website. Access the old version .
CellsCells
  • Review
  • Open Access

26 February 2020

16 Pages

The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias

and
1
Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
2
Centro de Investigación Médica Aplicada (CIMA), University of Navarra, 31008 Pamplona, Spain
3
Biochemistry and Genetics Department, University of Navarra, 31008 Pamplona, Spain
4
IdiSNA, Instituto de Investigación Sanitaria de Navarra, 31008 Pamplona, Spain
This article belongs to the Special Issue Regulation and Function of the Myc Oncogene

Abstract

The MYC transcription factor is one of the best characterized PP2A substrates. Deregulation of the MYC oncogene, along with inactivation of PP2A, are two frequent events in cancer. Both proteins are essential regulators of cell proliferation, apoptosis, and differentiation, and they, directly and indirectly, regulate each other’s activity. Studies in cancer suggest that targeting the MYC/PP2A network is an achievable strategy for the clinic. Here, we focus on and discuss the role of MYC and PP2A in myeloid leukemias.
Keywords:
PP2A; MYC; myeloid leukemia; AML; CML

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.